packagePegaspargase

pegaspargase

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Pegaspargase is a PEGylated asparaginase enzyme used as an antineoplastic drug to treat lymphoid leukemias and lymphomas, including acute lymphoblastic leukemia/lymphoma. It is an approved medicine, with one product authorised in the European Union for precursor cell lymphoblastic leukemia-lymphoma, and it is also used in the United States.

Summary written by glm-5.3-flash from Wikidata Q7160547 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:pegaspargase
ATC codes:L01XX24
DrugBank:DB00059
Wikidata:Q7160547
molar mass:31731.9 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown